Skip to main content
. 2021 Dec 9;12:769069. doi: 10.3389/fendo.2021.769069

Figure 5.

Figure 5

Glucagon-like peptide-1 receptor agonists (GLP-lRAs); subcutaneous fat (SAT); SD, standard deviation; CI, confidence interval; IV, inverse variance; Guo-l, concluded liraglutide vs insulin; Yan-1, concluded liraglulide vs sitagliptin.